SAMe: Benefits, Forms, Dosing, and Side Effects

SAMe: Benefits, Forms, Dosing, and Side Effects

Last Updated:

SAMe (S-adenosyl-L-methionine) is a naturally occurring compound found in every cell in the body, manufactured from the essential amino acid methionine with the assistance of vitamin B-12 and methylfolate [1]. SAMe assists the body in producing neurotransmitters (dopamine and serotonin) and cartilage components (glycosaminoglycans).

SAMe has been most studied for depression and osteoarthritis, with additional research on fibromyalgia, Parkinson's disease depression, and liver disease.

SAMe synthesis in the body depends on adequate vitamin B-12 and methylfolate. MicroVitamin includes methylated B-12 and methylfolate (5-MTHF) — the bioavailable forms used directly in the methylation cycle.

Table of Contents

Overview

SAMe (S-adenosyl-L-methionine, also known as SAM-e, ademethionine, or AdoMet) is a naturally occurring compound found in every cell in the body, where it is manufactured from the essential amino acid methionine with the assistance of vitamin B-12 and methylfolate [1].

SAMe assists the body in producing a wide range of compounds, including neurotransmitters (dopamine and serotonin) and cartilage components (glycosaminoglycans). When natural SAMe levels are low, supplementation may facilitate production of these compounds.

Forms and Bioavailability

SAMe in supplements is produced synthetically in several stabilized forms:

  • Tosylate / disulfate tosylate / disulfate ditosylate — the most common forms in U.S. supplements and the most used in clinical studies.
  • 1,4-butanedisulfonate (Actimet) — an alternative form. A clinical study using 800 mg daily showed comparable efficacy to the tricyclic antidepressant imipramine [3].

Considering SAMe for Mood or Joint Health?

SAMe works alongside B vitamins and methylation pathways. Get a personalized supplement plan that accounts for your whole health picture with Health Roadmap.

Get Your Personalized Health Plan

Important dosing note: the stabilizing compounds weigh approximately as much as the SAMe molecule itself. A tablet containing 200 mg of "S-adenosyl-methionine disulfate tosylate" contains only 100 mg of actual SAMe. Verify the Supplement Facts panel lists the SAMe amount, not the total salt weight.

SAMe is highly susceptible to moisture degradation. Products in blister packaging (individually sealed tablets) are preferable to bottles. Take on an empty stomach for best absorption; if nausea occurs, use enteric-coated products or take with food.

Evidence for Benefits

Depression

SAMe is one of the most studied natural therapies for major depression. Several studies show it is as effective as tricyclic antidepressants [3][4][5].

As an adjunct therapy, 1,600 mg/day of SAMe added to SRI treatment for six weeks helped 46.1% of non-responders versus 35.8% with SRI plus placebo [6]. However, a lower dose of 800 mg/day (plus B vitamins) did not improve symptoms more than placebo in patients already on antidepressant medication [7].

In people not taking antidepressants, 800 mg/day produced slight improvement in the mildest form of major depression, but not in moderate to severe forms [8]. SAMe appears less effective than SSRIs but may have a more favorable side effect profile.

Osteoarthritis

SAMe at approximately 1,200 mg/day has been found to be about as effective as leading anti-inflammatory drugs for osteoarthritis pain. SAMe took longer to show benefit but the effect lasted longer and had fewer side effects [9][10][11][12].

However, when compared directly to placebo, results are mixed. Analyses showed SAMe did not significantly reduce pain and only slightly improved functional limitation [14][15]. SAMe is unlikely to help with severe osteoarthritis with bone-on-bone contact.

Parkinson's Disease Depression

A small study found that SAMe (400 mg oral twice daily plus 200 mg intramuscular) for 30 days improved depression symptoms in Parkinson's patients compared to placebo [16]. An open-label study found 800–3,600 mg/day for 10 weeks improved depression by at least 50% in nearly all participants [17].

Fibromyalgia

A study of 44 people found that 800 mg/day for six weeks slightly reduced pain at rest and fatigue, but did not significantly improve tender point scores, pain during activity, depression, medication use, or sleep quality compared to placebo [18].

Liver Disease

Animal research showed SAMe protected against liver injury in a MASH model [19]. However, preliminary human research found that SAMe at 1,000–2,000 mg/day for six weeks did not improve liver enzymes or fibrosis markers.

  • Depression: 400–1,600 mg/day; most studies used 1,600 mg/day
  • Osteoarthritis: 1,200 mg/day
  • Fibromyalgia: 800 mg/day
  • Liver disease: 1,200–1,600 mg/day

Improvements may take days to five weeks to become noticeable. Divide doses if taking more than 400 mg.

SAMe, Homocysteine, and B Vitamins

SAMe is converted to homocysteine in the body, but short-term studies up to 1,600 mg/day have not shown increased homocysteine levels [20][21]. The body converts homocysteine to glutathione using B6, B12, and folate [22]. As long as dietary B vitamin intake is adequate, additional B supplementation should not be necessary.

Safety and Side Effects

SAMe is generally considered safe at appropriate doses. Reported side effects include nausea and stomach upset (reducible with enteric-coated products), strange taste in the mouth [8], and drowsiness at higher doses (1,600 mg/day) [23].

One suspected serotonergic reaction leading to hospitalization was reported (800 mg/day combined with antidepressants), which resolved quickly [7]. Laboratory studies suggest excess SAMe can produce potentially toxic metabolites and lengthen circadian rhythms, though proportionate human-equivalent doses did not cause adverse effects over one month [24].

Drug Interactions

  • Antidepressants (SSRIs, SNRIs, MAO inhibitors, tricyclics): SAMe should not be taken with antidepressants without physician supervision due to risk of serotonergic reactions [7].
  • Levodopa (Parkinson's disease): SAMe may relieve levodopa side effects but might reduce its effectiveness over time [25].
  • Bipolar disorder: SAMe can trigger manic episodes in people with bipolar disorder [26].

Dietary Sources

SAMe is not obtained directly from food. The body synthesizes it from the amino acid methionine, found in protein-rich foods including meat, fish, dairy, eggs, nuts, and seeds. Adequate intake of vitamin B-12 and folate is necessary for SAMe synthesis.

Considering SAMe for Mood or Joint Health?

SAMe works alongside B vitamins and methylation pathways. Get a personalized supplement plan that accounts for your whole health picture with Health Roadmap.

Get Your Personalized Health Plan

References

    1. Bottiglieri T, Am J Clin Nutr, 2002.

    2. Travagli RA et al., Eur J Pharmacol, 1994.

    3. Delle Chiaie R et al., Am J Clin Nutr, 2002.

    4. Salmaggi P et al., Psychother Psychosom, 1993.

    5. Kagan BL et al., Am J Psychiatry, 1990.

    6. Papakostas GI et al., Am J Psychiatry, 2010.

    7. Sarris J et al., Eur Neuropsychopharmacol, 2018.

    8. Sarris J et al., Psychopharmacology (Berl), 2019.

    9. Kim J et al., Clin Ther, 2009.

    10. Najm WI et al., BMC Musculoskelet Disord, 2004.

    11. Domljan Z et al., Int J Clin Pharmacol Ther Toxicol, 1989.

    12. Muller-Fassbender H et al., Am J Med, 1987.

    13. Caruso I et al., Am J Med, 1987.

    14. Bradley JD et al., J Rheumatol, 1994.

    15. Rutjes AW et al., Cochrane Database Syst Rev, 2009.

    16. Carrieri PB et al., Curr Ther Res, 1990.

    17. Di Rocco A et al., Mov Disord, 2000.

    18. Jacobsen S et al., Scand J Rheumatol, 1991.

    19. Noureddin M et al., Exp Biol Med (Maywood), 2015.

    20. Thompson MA et al., J Altern Complement Med, 2009.

    21. Goren JL et al., Pharmacotherapy, 2004.

    22. Obeid R et al., Nutrients, 2013.

    23. Arnold LM et al., Eur Neuropsychopharmacol, 2005.

    24. Fukumoto K et al., Commun Biol, 2022.

    25. Muller T et al., Clin Neuropharmacol, 2005.

    26. Cuomo A et al., Ann Gen Psychiatry, 2020.

About Dr. Brad Stanfield

Dr Brad Stanfield

Dr. Brad Stanfield is a General Practitioner in Auckland, New Zealand, with a strong emphasis on preventative care and patient education. Dr. Stanfield is involved in clinical research, having co-authored several papers, and is a Fellow of the Royal New Zealand College of General Practitioners. He also runs a YouTube channel with over 319,000 subscribers, where he shares the latest clinical guidelines and research to promote long-term health. Keep reading...

Website LinkedIn YouTube
Back to blog